リアルタイムPCR市場 - 世界の産業規模、シェア、動向、機会、予測：製品別、用途別、エンドユーザー別、地域別、競合、2020年～2030年

世界のリアルタイムPCR市場は、2024年に43億3,000万米ドルと評価され、2030年までのCAGRで4.56%の成長が予測されています。

リアルタイムPCRは、PCRの原理を応用した分子生物学の実験技術です。臨床診断や獣医診断、食品安全の分野において、リアルタイムPCRは様々な微生物を検出、定量、同定するための確立された技術として大きな認知を得ています。PCRの原理は一見単純なように見えますが、この技術の開発者と使用者は定量PCR（qPCR）に関連する特定の懸念事項を認識しておくことが極めて重要です。例えば、WHO2024によると、Cepheid社のXpert MpoxリアルタイムPCR検査は、10月25日に緊急使用リスト（EUL）に掲載されました。GeneXpertシステム用に設計されたこの検査は、使いやすく、完全に自動化されており、40分以内に結果が得られます。この検査は、サル痘ウイルスクレードIIのDNAを検出し、分散型のニアポイントオブケア診断をサポートします。

このような懸念には、用語や定義の正確な使用、PCR原理の包括的な理解、データの解釈と提示に関する課題、さまざまな微生物診断アプリケーションにおけるqPCRの限界などが含まれます。qPCRの性能を説明するために不可欠なパラメータも考慮する必要があります。リアルタイムPCRでは、PCR産物を検出するために一般的に使用される2つの手法があります。第1の手法は、あらゆる二本鎖DNAに挿入される非特異的蛍光色素を用いるものです。第2の手法は蛍光レポーターで標識されたオリゴヌクレオチドである配列特異的DNAプローブを用いるものです。これらのプローブは、相補配列とのハイブリダイゼーション後にのみ検出が可能となります。これらの複雑な細部に取り組むことで、研究者や実務者はそれぞれの分野でリアルタイムPCRを正確かつ効果的に使用することができ、分子診断や微生物分析の進歩に貢献することができます。

市場促進要因

様々な疾患や遺伝性疾患の増加

主な市場課題

機器の高コスト

主な市場動向

自動化およびロボット工学との統合

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のリアルタイムPCR市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別（試薬・消耗品、機器、ソフトウェア・サービス）
  • 用途別（臨床診断、研究、法医学）
  • エンドユーザー別（病院、診断センター、製薬会社、CRO、バイオテクノロジー企業、研究所、学術機関、法医学研究所）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 北米のリアルタイムPCR市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州のリアルタイムPCR市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域のリアルタイムPCR市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米のリアルタイムPCR市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのリアルタイムPCR市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 世界のリアルタイムPCR市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Thermo Fisher Scientific, Inc.
• Bio-Rad Laboratories, Inc.
• F. Hoffman-La Roche Ltd.
• Abbott Laboratories Inc.
• Agilent Technologies, Inc.
• Becton Dickinson and Company
• Enzo Life Sciences, Inc.
• Promega Corporation
• Biomerieux S.A.
• Cole-Parmer Instrument Company Llc

第16章 戦略的提言

第17章 調査会社について・免責事項

Global Real Time PCR Market was valued at USD 4.33 Billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 4.56% through 2030F. Real-time polymerase chain reactions (PCR) are molecular biology laboratory techniques that build upon the principles of PCR. In the fields of clinical and veterinary diagnostics, as well as food safety, real-time PCR has gained significant recognition as a well-established technology for detecting, quantifying, and identifying various microbial agents. While the PCR principle may seem straightforward, it is crucial for creators and users of this technology to be aware of specific concerns associated with quantitative PCR (qPCR). For instance, according to WHO 2024, the Xpert Mpox real-time PCR test by Cepheid was listed under its Emergency Use Listing (EUL) on October 25. Designed for GeneXpert systems, the test is easy to use, fully automated, and delivers results in under 40 minutes. It detects monkeypox virus clade II DNA and supports decentralized, near-point-of-care diagnostics.

These concerns include the accurate use of terminology and definitions, a comprehensive understanding of the PCR principle, challenges related to data interpretation and presentation, as well as limitations of qPCR in different microbial diagnostic applications. Parameters that are vital for describing qPCR performance also need to be taken into consideration. In real-time PCR, there are two commonly used techniques for detecting PCR products. The first technique involves non-specific fluorescent dyes that intercalate with any double-stranded DNA. The second technique utilizes sequence-specific DNA probes, which are oligonucleotides labeled with fluorescent reporters. These probes enable detection only after hybridization with the complementary sequence. By addressing these intricate details, researchers and practitioners can ensure the accurate and effective use of real-time PCR in their respective fields, contributing to advancements in molecular diagnostics and microbial analysis.

Key Market Drivers

Rising Incidences of Different Diseases and Genetic Disorders

A study conducted by the Journal of the Royal Society Interface reveals a significant rise in disease levels since 1980. It indicates that nearly 30% of diseases are responsible for a staggering 80% of outbreaks, highlighting the urgent need for effective disease prevention and management strategies. The genetic disorders have become increasingly prevalent in recent times, posing a major challenge to global healthcare systems. For instance, according to a 2024 article, scientists identified a genetic disorder linked to mutations in the RNU4-2 gene, associated with severe developmental delays. The discovery may affect thousands globally, with hundreds already diagnosed. This breakthrough offers new insights into genetic conditions and potential pathways for diagnosis and treatment.

According to the World Health Organization (WHO), genetic disorders now account for over 28% of hospital admissions and are a leading cause of childhood mortality, contributing to almost 50% of childhood deaths. These statistics underscore the critical importance of prenatal diagnosis and carrier testing for genetic disorders. In this context, quantitative polymerase chain reaction (qPCR) have emerged as the preferred techniques for accurate and reliable genetic testing. qPCR has long played a pivotal role in diagnosing diseases by investigating bacteria and viruses, while dPCR, although still an emerging technology, has demonstrated its ability to enhance the detection of extremely precise gene mutations.

The advancements in real-time PCR technologies have propelled the market forward, opening up new possibilities for improved disease diagnosis, genetic screening, and personalized medicine. As researchers continue to uncover the complexities of the human genome, the demand for innovative PCR solutions is expected to grow, leading to further advancements in the field. The findings of the study emphasize the pressing need for continued research, innovation, and collaboration in the realm of disease prevention and genetic testing. By staying at the forefront of scientific developments, we can strive to mitigate the impact of diseases and genetic disorders, ultimately improving global health outcomes.

Key Market Challenges

High Cost of Instruments

The equipment and tools required for conducting PCR tests, particularly qPCR equipment, are often on the higher end in terms of cost. According to multiple sources, the price range for dPCR or qPCR machinery can vary from $15,000 to well over $100,000, depending on the specific model and features. This significant investment is not limited to the initial purchase alone. There are also ongoing expenses to consider, such as the annual operational costs of cyclers and the cost of universal probe mastermixes.

These hidden costs can accumulate over time and pose challenges to market growth, especially in both developing and developed economies. The considerable financial implications associated with acquiring and maintaining the equipment may deter potential users or limit accessibility, hindering the expansion of PCR testing in various settings.

The costs associated with PCR testing go beyond the equipment itself. Additional expenses can arise from sample preparation, consumables, reagents, and the need for skilled personnel to operate and maintain the equipment. All of these factors contribute to the overall cost and complexity of implementing PCR testing in different healthcare settings. As the demand for PCR testing continues to rise, efforts to address these challenges are crucial. Finding ways to reduce costs, increase affordability, and streamline the process can help make PCR testing more accessible and widespread, ultimately benefiting healthcare systems, researchers, and patients alike.

Key Market Trends

Integration with Automation and Robotics

The integration of real-time polymerase chain reaction (PCR) with automation and robotic systems holds significant promise in increasing efficiency and reducing user-dependent variability across various fields, particularly in clinical diagnostics, high-throughput screening, and large-scale research projects. Automated real-time PCR systems are designed to execute tasks with a high degree of precision and consistency. Robots can accurately dispense reagents, mix samples, and perform thermal cycling, minimizing human errors and ensuring reproducibility of results. This is especially crucial in clinical diagnostics, where accuracy is paramount.

Automated systems can handle a large number of samples simultaneously, significantly increasing throughput. This is particularly valuable in high-throughput screening applications, where hundreds or thousands of samples need to be processed quickly, such as in drug discovery, genomics, or epidemiology studies. Automated systems often incorporate sample tracking and data management software, ensuring full traceability of samples throughout the PCR process. This feature enhances data integrity, minimizes the risk of sample mix-up, and simplifies record-keeping, which is vital in clinical diagnostics and regulatory compliance.

Key Market Players

• Thermo Fisher Scientific, Inc.
• Bio-Rad Laboratories, Inc.
• F. Hoffman-La Roche Ltd.
• Abbott Laboratories Inc.
• Agilent Technologies, Inc.
• Becton Dickinson and Company
• Enzo Life Sciences, Inc.
• Promega Corporation
• Biomerieux S.A.
• Cole-Parmer Instrument Company Llc

Report Scope:

In this report, the Global Real Time PCR Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Real Time PCR Market, By Product:

• Reagents & Consumables
• Instruments
• Software & Services

Real Time PCR Market, By Application:

• Clinical Diagnostics
• Research
• Forensic

Real Time PCR Market, By End User:

• Hospitals and Diagnostic Centres
• Pharmaceutical
• CROs and Biotechnology Companies
• Research Laboratories and Academic Institutes
• Forensic Laboratories

Real Time PCR Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Real Time PCR Market.

Available Customizations:

Global Real Time PCR market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Real Time PCR Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Reagents & Consumables, Instruments, Software & Services)
  • 5.2.2. By Application (Clinical Diagnostics, Research, Forensic)
  • 5.2.3. By End User (Hospitals and Diagnostic Centers, Pharmaceutical, CROs and Biotechnology Companies, Research Laboratories and Academic Institutes, Forensic Laboratories)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Real Time PCR Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Real Time PCR Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Real Time PCR Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Real Time PCR Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Real Time PCR Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Real Time PCR Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. United Kingdom Real Time PCR Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. Italy Real Time PCR Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecasty
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. France Real Time PCR Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Real Time PCR Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia-Pacific Real Time PCR Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Real Time PCR Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Real Time PCR Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Real Time PCR Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Real Time PCR Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Real Time PCR Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. South America Real Time PCR Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Real Time PCR Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Real Time PCR Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Real Time PCR Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Real Time PCR Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Real Time PCR Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Real Time PCR Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Real Time PCR Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Real Time PCR Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Thermo Fisher Scientific, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Service Offerings
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Bio-Rad Laboratories, Inc.
• 15.3. F. Hoffman-La Roche Ltd.
• 15.4. Abbott Laboratories Inc.
• 15.5. Agilent Technologies, Inc.
• 15.6. Becton Dickinson and Company
• 15.7. Enzo Life Sciences, Inc.
• 15.8. Promega Corporation
• 15.9. Biomerieux S.A.
• 15.10. Cole-Parmer Instrument Company Llc

16. Strategic Recommendations

17. About Us & Disclaimer